Institution
University of Zimbabwe
Education•Harare, Harare, Zimbabwe•
About: University of Zimbabwe is a education organization based out in Harare, Harare, Zimbabwe. It is known for research contribution in the topics: Population & Acquired immunodeficiency syndrome (AIDS). The organization has 4378 authors who have published 6800 publications receiving 160720 citations. The organization is also known as: UZ & University College of Rhodesia and Nyasaland.
Topics: Population, Acquired immunodeficiency syndrome (AIDS), Public health, Agriculture, Health care
Papers published on a yearly basis
Papers
More filters
••
TL;DR: New information increases concerns about DMPA and HIV acquisition risk in women, and data for other hormonal contraceptive methods, including norethisterone enanthate, are largely reassuring.
Abstract: We are grateful to Sharon Achilles for her thoughtful input related to describing potential biological mechanisms, and to all study investigators who provided additional information about their analyses WHO provided support for the writing of this systmatic review and for the writing group to attend a working meeting in Geneva, Switzerland in October 2015 DJW was partially funded by NIH DP2-HD-08-4070 The review was conducted independently of the WHO guidance development process; and conclusions represent the independent opinions of the authors The findings and conclusions in this article do not necessarily reflect the positions and policies of the donor Role of authors: The World Health Organization (JNK and PSS) initiated the idea to conduct this systematic review update CBP led the conduct of the systematic review, including conducting the systematic literature search and drafting the manuscript CBP, KMC, and PCH screened titles, abstracts, and full-text manuscripts to determine study inclusion SJP conducted the statistical meta-analysis All coauthors (CBP, KMC, PCH, SJP, TC, JNK, DJW, and PSS) participated in framing the study question, developing the quality criteria, abstracting study information and assessing study quality, interpreting the data, and contributing to the writing and editing of the manuscript Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official positions of the Guttmacher Institute, the Centers for Disease Control and Prevention, the World Health Organization, the National Institutes of Health, or other institutions with which the authors are affiliated
171 citations
••
TL;DR: Fundamental research is needed to conduct fundamental research to demonstrate the benefits of biochar applications, and develop policy framework and criteria for its production and subsequent adoption.
170 citations
••
TL;DR: Postpartum maternal or neonatal vitamin A supplementation may not reduce infant mortality in infants of HIV-negative women with an apparently adequate vitamin A status.
169 citations
••
TL;DR: An antenatal care programme with fewer more objectively oriented visits can be introduced without adverse effects on the main intermediate outcome pregnancy variables.
167 citations
••
TL;DR: VCT at the workplace offers the potential for high uptake when offered on-site and linked to basic HIV care, and convenience and accessibility appear to have critical roles in the acceptability of community-based VCT.
Abstract: BACKGROUND: HIV counselling and testing is a key component of both HIV care and HIV prevention, but uptake is currently low. We investigated the impact of rapid HIV testing at the workplace on uptake of voluntary counselling and testing (VCT). METHODS AND FINDINGS: The study was a cluster-randomised trial of two VCT strategies, with business occupational health clinics as the unit of randomisation. VCT was directly offered to all employees, followed by 2 y of open access to VCT and basic HIV care. Businesses were randomised to either on-site rapid HIV testing at their occupational clinic (11 businesses) or to vouchers for off-site VCT at a chain of free-standing centres also using rapid tests (11 businesses). Baseline anonymised HIV serology was requested from all employees. HIV prevalence was 19.8% and 18.4%, respectively, at businesses randomised to on-site and off-site VCT. In total, 1,957 of 3,950 employees at clinics randomised to on-site testing had VCT (mean uptake by site 51.1%) compared to 586 of 3,532 employees taking vouchers at clinics randomised to off-site testing (mean uptake by site 19.2%). The risk ratio for on-site VCT compared to voucher uptake was 2.8 (95% confidence interval 1.8 to 3.8) after adjustment for potential confounders. Only 125 employees (mean uptake by site 4.3%) reported using their voucher, so that the true adjusted risk ratio for on-site compared to off-site VCT may have been as high as 12.5 (95% confidence interval 8.2 to 16.8). CONCLUSIONS: High-impact VCT strategies are urgently needed to maximise HIV prevention and access to care in Africa. VCT at the workplace offers the potential for high uptake when offered on-site and linked to basic HIV care. Convenience and accessibility appear to have critical roles in the acceptability of community-based VCT.
166 citations
Authors
Showing all 4433 results
Name | H-index | Papers | Citations |
---|---|---|---|
Didier Raoult | 173 | 3267 | 153016 |
Roy M. Anderson | 116 | 526 | 65549 |
Vikram Patel | 116 | 654 | 59717 |
Richard M. Cowling | 96 | 392 | 30042 |
Ken E. Giller | 92 | 555 | 36374 |
Leif Bertilsson | 87 | 321 | 23933 |
Johan Rockström | 85 | 236 | 57842 |
Alex Aiken | 77 | 295 | 20254 |
Frances M. Cowan | 76 | 456 | 19984 |
Robert J. Biggar | 73 | 231 | 18474 |
Charles A. Thornton | 71 | 182 | 17195 |
David Wilson | 69 | 618 | 18780 |
David Katzenstein | 69 | 280 | 21239 |
Bruce M. Campbell | 67 | 227 | 17616 |
David Sanders | 65 | 492 | 17119 |